NM_138694.4:c.11786-30C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_138694.4(PKHD1):c.11786-30C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.17 in 1,575,624 control chromosomes in the GnomAD database, including 24,270 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 1908 hom., cov: 33)
Exomes 𝑓: 0.17 ( 22362 hom. )
Consequence
PKHD1
NM_138694.4 intron
NM_138694.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0380
Publications
5 publications found
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
PKHD1 Gene-Disease associations (from GenCC):
- autosomal recessive polycystic kidney diseaseInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet
- polycystic kidney disease 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
- Caroli diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 6-51619550-G-A is Benign according to our data. Variant chr6-51619550-G-A is described in ClinVar as Benign. ClinVar VariationId is 262386.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.344 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PKHD1 | ENST00000371117.8 | c.11786-30C>T | intron_variant | Intron 66 of 66 | 1 | NM_138694.4 | ENSP00000360158.3 | |||
| ENSG00000228689 | ENST00000454361.1 | n.81-2805G>A | intron_variant | Intron 1 of 1 | 3 | |||||
| ENSG00000228689 | ENST00000589278.6 | n.811-2810G>A | intron_variant | Intron 2 of 2 | 5 | |||||
| ENSG00000228689 | ENST00000650088.1 | n.222-2805G>A | intron_variant | Intron 1 of 1 |
Frequencies
GnomAD3 genomes AF: 0.146 AC: 22195AN: 152016Hom.: 1908 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
22195
AN:
152016
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.176 AC: 43306AN: 246564 AF XY: 0.179 show subpopulations
GnomAD2 exomes
AF:
AC:
43306
AN:
246564
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.173 AC: 245822AN: 1423490Hom.: 22362 Cov.: 25 AF XY: 0.174 AC XY: 123577AN XY: 710710 show subpopulations
GnomAD4 exome
AF:
AC:
245822
AN:
1423490
Hom.:
Cov.:
25
AF XY:
AC XY:
123577
AN XY:
710710
show subpopulations
African (AFR)
AF:
AC:
2344
AN:
32770
American (AMR)
AF:
AC:
4682
AN:
44640
Ashkenazi Jewish (ASJ)
AF:
AC:
4068
AN:
25876
East Asian (EAS)
AF:
AC:
12782
AN:
39480
South Asian (SAS)
AF:
AC:
17067
AN:
85268
European-Finnish (FIN)
AF:
AC:
9383
AN:
52834
Middle Eastern (MID)
AF:
AC:
773
AN:
5712
European-Non Finnish (NFE)
AF:
AC:
184985
AN:
1077902
Other (OTH)
AF:
AC:
9738
AN:
59008
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
9936
19873
29809
39746
49682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6578
13156
19734
26312
32890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.146 AC: 22199AN: 152134Hom.: 1908 Cov.: 33 AF XY: 0.149 AC XY: 11073AN XY: 74356 show subpopulations
GnomAD4 genome
AF:
AC:
22199
AN:
152134
Hom.:
Cov.:
33
AF XY:
AC XY:
11073
AN XY:
74356
show subpopulations
African (AFR)
AF:
AC:
3162
AN:
41514
American (AMR)
AF:
AC:
1788
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
529
AN:
3464
East Asian (EAS)
AF:
AC:
1852
AN:
5178
South Asian (SAS)
AF:
AC:
1065
AN:
4820
European-Finnish (FIN)
AF:
AC:
1923
AN:
10578
Middle Eastern (MID)
AF:
AC:
34
AN:
292
European-Non Finnish (NFE)
AF:
AC:
11371
AN:
67972
Other (OTH)
AF:
AC:
285
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
950
1900
2851
3801
4751
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
254
508
762
1016
1270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
826
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal recessive polycystic kidney disease Benign:1
Apr 12, 2018
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Polycystic kidney disease 4 Benign:1
Jun 19, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.